Related content

Estrogen and postmenopausal estrogen/progestin therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production

By Mikkola T.   Viinikka L.   Ylikorkala O.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 79, Iss. 1, 1998-07 ,pp. : 75-82

Elsevier

Access to resources Recommend Favorite

Differing effects of low-dose estrogen–progestin therapy and pravastatin in postmenopausal hypercholesterolemic women

By Davis S. R.   Goldstat R.   Newman A.   Berry K.   Burger H. G.   Meredith I.   Koch K.  

Climacteric, Vol. 5, Iss. 4, 2002-12 ,pp. : 341-350

Informa Healthcare

Access to resources Recommend Favorite

The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women

By Keramaris N. C.   Christodoulakos G. E.   Lambrinoudaki I. V.   Dalamanga A.   Alexandrou A. P.   Bramis J.   Bastounis E.   Creatsas G. C.  

Climacteric, Vol. 10, Iss. 5, 2007-10 ,pp. : 400-407

Informa Healthcare

Access to resources Recommend Favorite

Is combined estrogen/progestogen hormone therapy worth the risk?

By Sturdee David W.   MacLennan Alastair H.  

Climacteric, Vol. 6, Iss. 3, 2003-09 ,pp. : 177-179

Informa Healthcare

Access to resources Recommend Favorite

Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial

By Shapiro S.  

Climacteric, Vol. 6, Iss. 4, 2003-12 ,pp. : 302-313

Informa Healthcare

Access to resources Recommend Favorite